What Bridge Informatics does

Bridge Informatics is a Cambridge, Massachusetts-based professional services firm that delivers bioinformatics and computational biology services to life sciences organizations. The company operates as a managed service provider (MSP) targeting pharmaceutical, biotechnology, diagnostic, academic, and government clients that require specialized expertise in genomics, transcriptomics, proteomics, single-cell RNA-seq, spatial transcriptomics, and multi-omics analysis. Its service portfolio spans six interconnected lines: bioinformatics and computational biology analysis, cloud architecture and maintenance on AWS/Azure/GCP, data mining, software and database engineering, flexible staffing, and publication support. The company runs fully remote with team members across the United States and Spain, founded by CEO Dan Ryder, PhD.

The firm's underlying technology stack combines custom bioinformatics pipelines built on workflow management systems (Snakemake, Nextflow) with containerization for reproducibility, GPU-accelerated preprocessing using RAPIDS for full-resolution single-cell analysis, and AI/ML components including deep learning prediction models and scGPT foundation model embeddings. Bridge Informatics also deploys autonomous AI agents (built on the Claude/Anthropic Skills framework) for pipeline orchestration, input validation, automated error recovery, and regulatory QA support. Notable technical differentiators include multi-omics integration capabilities, AI-powered disease risk and treatment response modeling, and a scalable AI framework for GLP-1 biology analysis presented at Bio-IT World 2026. The firm holds verified MSP status on Science Exchange and Scientist.com and has co-authored research published in Science Translational Medicine with Marengo Therapeutics.

Bridge Informatics monetizes primarily through professional services engagements, including project-based bioinformatics analysis, flexible staffing solutions billed on customizable engagement lengths spanning weeks to multi-year contracts, and managed cloud infrastructure services. The go-to-market is direct enterprise field sales led by Head of Business Development Jessica Corrado, complemented by marketplace-driven distribution through Science Exchange and Scientist.com. Pricing is not publicly disclosed but follows quote-based models for custom services and retainer structures for ongoing support. The company is founder-led, bootstrapped with no external institutional funding disclosed, and is governed by a board that includes veterans from Millennium Pharmaceuticals, Synlogic, Merck, Novartis, and multiple AI-driven drug discovery ventures.

Name

Bridge Informatics

Legal name

Bridge Informatics

Website

https://bridgeinformatics.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Bridge Informatics is a professional services firm providing bioinformatics and computational biology services to life sciences companies. It delivers custom data analysis, pipeline development, cloud infrastructure, and staffing solutions to pharmaceutical, biotech, diagnostic, academic, and government clients.

Ownership category

akta.pro rank

Product category

Bioinformatics Services

NAICS

Other Scientific and Technical Consulting Services (54169), Computer Systems Design and Related Services (54151), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)

SIC

Services-Management Consulting Services (8742), Services-Computer Programming Services (7371), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), Healthcare IT & Health Informatics Staffing (BPACADAK)

Keywords

• Bioinformatics services
• Genomics data analysis
• Computational biology consulting
• Cloud infrastructure management
• Life sciences staffing

Headquarters

HQ city

Salem

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Professional Services - Bioinformatics & Computational Biology: Bioinformatics analysis services including custom script guided by computational specifications, experimental design advice, data preprocessing, analysis, and summary of findings. Services can include or exclude pipeline generation.
2. Staffing Solutions: Flexible staffing solutions providing biologists, computational scientists, software engineers, bioinformaticians, business strategists, and executive leaders. Customizable engagement lengths and weekly commitment levels with straightforward pricing models.
3. Cloud Architecture & Maintenance: Building and maintaining cloud-based or hybrid data infrastructure on AWS, Azure, or GCP. Includes storage infrastructure, remote access regulation, data transfer facilitation, and ongoing maintenance and optimization.
4. Software & Database Engineering: Full-stack software development services including roadmap building, application development, deployment, security, monitoring, and maintenance. Cloud deployment options on AWS, Azure, or GCP.
5. Publication Services: Assistance with publication process including brainstorming goals, identifying journals, writing manuscript sections, and revising based on reviewer feedback.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Bridge Informatics is a managed service provider delivering professional bioinformatics and computational biology services to life science organizations. The company provides custom genomic and multi-omics data analysis, builds reproducible analysis pipelines, manages cloud infrastructure on AWS/Azure/GCP, supplies flexible staffing of bioinformaticians and software engineers, develops custom scientific software, and supports scientific publication efforts.

Product overview

Bridge Informatics is a managed service provider (MSP) specializing in professional services and R&D solutions for life science companies. The company operates as a unified service portfolio organized into six interconnected service lines: Bioinformatics & Computational Biology Services (core analytical work including genomic analysis, biomarker discovery, and custom pipeline development), Cloud Management Services (infrastructure architecture and maintenance on AWS/Azure/GCP), Data Mining Services (sourcing and analyzing public/private biological datasets), Software & Database Engineering Services (full-stack custom application development and deployment), Staffing Solutions (flexible talent augmentation), and Publication Services (scientific manuscript support). These services are designed to work together, allowing clients to engage Bridge Informatics for standalone projects or comprehensive R&D support spanning data generation, analysis, infrastructure, and dissemination.

Differentiator

Problem solved

Functional benefit

Products and services

• Bioinformatics & Computational Biology Services

Quantifiable outcome

• Reduced diagnostic timeline from seven years to less than one day in rare disease research with AI-powered genomic analysis
• +1 more outcomes

Named customers15 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability12 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• TFC TherapeuticscoreStrategic or Co-development PartnerCollaborative research partnership on tumor-macrophage hybrid (TMH) cell analysis for colorectal cancer research. Bridge Informatics developed a novel imputation-based workflow to identify TMH cells and presented joint poster at Bio-IT World 2026.
• Marengo TherapeuticscoreStrategic or Co-development PartnerMulti-year collaboration on single-cell RNA sequencing analysis and T-cell receptor research. Joint poster presentations at Bio-IT World 2025 on network maps for cluster identification in single-cell data for universal immunotherapies development.
• Akero TherapeuticscoreStrategic or Co-development PartnerCollaboration on developing scalable bioinformatics pipeline for variant detection from whole-genome and whole-exome sequencing data. Joint poster presentation at Bio-IT World 2025.
• Marengo TherapeuticscoreStrategic or Co-development PartnerCo-authored publication in Science Translational Medicine on T cell receptor β chain-directed antibody fusion molecule (STAR0602) for antitumor activity. Bridge Informatics contributed bioinformatics analysis.
• Science ExchangeminorChannel Partner/ Reseller/ DistributorMarketplace partnership where Science Exchange serves as a distribution channel for Bridge Informatics' bioinformatics services to their pharmaceutical and biotech clients.
• Scientist.comminorChannel Partner/ Reseller/ DistributorMarketplace partnership where Scientist.com serves as a distribution channel for Bridge Informatics' R&D professional services.
• PercayAIminorStrategic or Co-development PartnerCollaboration on NGS pipeline automation for RNAseq analysis, including training client team to run pipelines independently.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Velsera (formerly Seven Bridges Genomics): Velsera provides a bioinformatics platform combined with professional services for pharma, biotech, and clinical diagnostics customers. Direct competitor to Bridge Informatics in NGS analysis, multi-omics, and managed bioinformatics services for life sciences R&D.
• Dotmatics: Dotmatics offers a scientific R&D informatics platform spanning biology, chemistry, and lab data workflows. Comparable to Bridge in serving life sciences R&D teams with integrated data analysis, though Dotmatics leans more toward enterprise software and less toward bespoke bioinformatics services.
• Eagle Genomics: Eagle Genomics provides an AI-driven multi-omics platform with associated expert services for pharma, food, and personal care R&D. Closely comparable to Bridge's combination of bioinformatics platform, multi-omics expertise, and life-science-focused professional services.
• CD Genomics: CD Genomics is an outsourced genomics and bioinformatics services provider serving academic and industrial researchers. Direct competitor to Bridge in delivering NGS analysis, single-cell, and custom pipeline development services on a project basis.
• Novogene: Novogene is a global genomics and bioinformatics services company offering sequencing, analysis, and cloud-based bioinformatics platforms. Competes with Bridge for pharma/biotech NGS and multi-omics service contracts, with significantly larger scale.
• Strand Life Sciences: Strand Life Sciences provides bioinformatics software, clinical genomics, and R&D services to pharma, diagnostics, and research customers globally. Comparable to Bridge in combining bioinformatics analysis services with proprietary platforms for life sciences.

Broad incumbents

• Benchling: Benchling is a leading cloud-based lab informatics platform used across biotech R&D. Adjacent incumbent to Bridge, offering broader lab data management and notebook functionality rather than bespoke bioinformatics analysis services.
• Biomatters (Geneious): Biomatters offers Geneious Prime and related bioinformatics tools for DNA/RNA/protein analysis used widely by life science researchers. Adjacent incumbent offering platform tools where Bridge offers services; both compete for budget allocated to bioinformatics analysis.

Emerging players

• Basepair: Basepair offers an on-demand bioinformatics services platform for NGS analysis with rapid turnaround. Competes with Bridge in providing outsourced bioinformatics analysis to biotech and academic customers, with a more software-mediated delivery model.
• Aitia (formerly PrecisionLife): Aitia applies AI and multi-omics to drug discovery and patient stratification, partnering with pharma. Comparable to Bridge's AI-driven multi-omics positioning and pharma client base, though focused on drug-discovery insights rather than bioinformatics service delivery.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/bridge_info_usa
• YouTubeyoutube.com/@bridgeinformatics/videos
• Facebookfacebook.com/Bridge-Informatics-106012941428943
• LinkedInlinkedin.com/company/bridge-informatics

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bridge Informatics